Viral Vectors for Cell & Gene Therapy / Plasmid Manufacturing / Testing – CDMO
Genezen was poised for a major rebranding effort following its expansion into AAV development and manufacturing, complementing its existing LVV and RVV services. With the upcoming ASGCT conference as their stage, Genezen sought to make a bold statement. This strategy involved unveiling an eye-catching vertical exhibition structure designed to captivate attendees, showcase their comprehensive service portfolio, and cement Genezen’s position as a cutting-edge partner in viral vector manufacturing.